Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Teclistamab Shows Promise in Refractory Autoimmune Diseases
TOPLINE: Teclistamab, a T-cell engager that targets B-cell maturation antigen (BCMA), improved disease activity in four patients with refractory autoimmune conditions. In a separately published case report, teclistamab treatment induced remission in a patient with refractory systemic lupus erythematosus (SLE).…
English